General MedicationsINTRAMUSCULAR, INTRAVENOUSGeneric

CEFUROXIME SODIUM

Standard Dose

EQ 750MG BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CEFUROXIME SODIUM is listed in Drugs@FDA under application 065483 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL Sponsor HOSPIRA INC Submission history Latest submission status date: 2016-04-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFUROXIME SODIUM is listed in Drugs@FDA under application 065483 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL Sponsor HOSPIRA INC Submission history Latest submission status date: 2016-04-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.